← Back
$TEVA All transactions

TEVA PHARMACEUTICAL INDUSTRIES LTD

M

$ Value

Shares

9,632

Price

Filed

Jun 9

Insider

Name

Satchi-Fainaro Ronit

Title

CIK

0001742782

Roles

Director

Transaction Details

Transaction Date

2025-06-06

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

97,909

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. | Restricted share units were granted on June 6, 2024 and vested on June 6, 2025. | Restricted share units were granted on June 5, 2025 and vest on June 5, 2026.

Filing Info

Accession No.

0000950170-25-083756

Form Type

4

Issuer CIK

0000818686

Satchi-Fainaro Ronit's History

Date Ticker Type Value
2025-06-06 TEVA M
2025-06-06 TEVA M $0
2025-06-05 TEVA A $0

Other Insiders at TEVA (90d)

Insider Bought Sold Last
Francis Richard D
President and CEO
$31.1M 2026-03-05
Sabag Mark
See "Remarks"
2026-03-05
Daniell Richard
EVP, Europe Commercial
$7.7M 2026-03-05
Daniell Richard
Exec. VP, European Commercial
2026-01-27
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$11.6M 2026-03-05
Weiss Amir
Chief Accounting Officer
2026-03-05
Hughes Eric A
See "Remarks"
$3.3M 2026-03-05
Fox Christine
EVP, U.S. Commercial
$546K 2026-03-05
Shields Matthew
EVP, Global Operations
$548K 2026-03-05
Jover Placid
See "Remarks"
$448K 2026-03-05
Lippman Evan
EVP, Business Development
2026-03-04
Savage Brian
Interim Chief Legal Officer
$164K 2026-03-05